News

David Jones (1895–1974) was an artist, poet, writer and craftsman; a name synonymous with the Modernist era but one that still remains lesser known in comparison to his contemporaries... A new ...
Boston-based biotech PepGen Inc. (NASDAQ:PEPG) announced today it will discontinue all Duchenne muscular dystrophy (DMD) research after its lead candidate, PGN-EDO51, failed to achieve target ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
David Ignatius writes a twice-a-week foreign affairs column for The Washington Post. Ignatius has written 12 spy novels: “Phantom Orbit” (2024), “The Paladin” (2020), “The Quantum Spy ...
David J. Lynch joined The Washington Post in November 2017 from the Financial Times, where he covered white-collar crime. He was previously the cybersecurity editor at Politico and a senior writer ...
Edward Jones CD rates are competitive with several of the best CD rates out there. If you're looking to use CDs as part of your savings strategy, Edward Jones' brokered CDs may be worth considering.
All the latest news, photos and more from Welsh actress Catherine Zeta-Jones. Catherine started her acting career in the West End before making her move to the screen in the 1990s. She is married ...
Brooks and Capehart on the GOP struggle to elect a House speaker and Biden’s aid request New York Times columnist David Brooks and Washington Post associate editor Jonathan Capehart join Geoff ...
The future of Nippon Shinyaku’s Duchenne muscular dystrophy (DMD) therapy Viltepso has been thrown into doubt after it failed a clinical trial designed to upgrade its 2020 accelerated approval.
US to end use of race, gender in highway, transit contracts The Trump administration said on Wednesday it will end the U.S. Transportation Department's consideration of race or gender when ...
Alani Asis is a freelancer for Newsweek’s personal finance vertical. Alani has over three years of experience writing for personal finance brands such as Insider, Forbes and Fortune Magazine.